Research & Development

日日撸偷偷撸得得撸博腾股份扣非净利增长225% 与名企展开合作

發布時間︰

  “咳。”林徵羽掩飾性的咳了一下,臉上帶了點不自然的神色︰“你覺得我穿這身怎麼樣?”   說好的機場剛槍呢?還能不能行了,玩個游戲也被虐。一會兒大概不用去吃飯了吧,游戲里的狗糧已經吃飽了。日日撸   最後,陸昔年在箱子底部發現了真空包裝的一個等身抱枕,正反兩面都印著以Lin為原型漫畫人物。偷偷撸   “這樣的話希望Lin能天天遲到。”   那塊被他扯禿了的草皮依舊禿著,陸昔年只好祈求上天讓校草趕緊把這不和諧的小插曲忘掉,在他忘掉之前最好也不要遇見他。得得撸   年糕︰[驚]500就夠了,用不著這麼多。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo